title: Thyroid gland plasmacytoma with a dramatic and persistent complete response under thalidomide and dexamethasone-associated treatment.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Terrier
authors.forename: Achille
authors.initials: A
authors.lastname: Aouba
authors.forename: Saliou
authors.initials: S
authors.lastname: Diop
authors.forename: Jêrome
authors.initials: J
authors.lastname: Clerc
authors.forename: Viorel
authors.initials: V
authors.lastname: Vasiliu
authors.forename: Yves
authors.initials: Y
authors.lastname: Munera
authors.forename: Olivier
authors.initials: O
authors.lastname: Hermine
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D009101:Multiple Myeloma / Q000473:pathology; D010954:Plasmacytoma / Q000188:drug therapy*; D012008:Recurrence; D012074:Remission Induction; D013792:Thalidomide / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D007166:Immunosuppressive Agents; D013792:Thalidomide; D003907:Dexamethasone